Pituitary tumors Flashcards

1
Q

What is the % of pituitary tumors in relation to all primary brain tumors?

A

∼10%–15% of all diagnosed primary brain tumors are of pituitary origin with up to 25% seen on autopsy series

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What % of pituitary tumors are functional vs. nonfunctional?

A

75% of pituitary tumors are functional, while 25% are nonfunctional.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the sex and age predilection for pituitary tumors with symptomatic presentations?

A

Symptomatic pituitary tumors occur mostly in females. 70% occur from 30–50 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a heritable syndrome that predispose to pituitary tumors, and what is the inheritance pattern?

A

MEN-1 (3 “Ps”: pituitary, parathyroid, pancreas), 11q13 mutant/menin. Autosomal dominant inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Nelson syndrome?

A

Nelson syndrome is ACTH-secreting adenoma that develops after adrenalectomy (pts can develop hyperpigmentation of the skin d/t a melanocyte-stimulating hormone). These may be less responsive to RT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the embryonic derivatives of the ant pituitary vs. post pituitary?

A

Anterior: Rathke pouch (oral ectoderm)
Posterior: extension of the 3rd ventricle (neuroectoderm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the name for the bony structure that houses the pituitary?

A

The sella turcica houses the pituitary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the boundaries of the sella?

A

Tuberculum sellae anteriorly, dorsum sellae posteriorly, sphenoid sinus inferiorly, dural folds superiorly, and post clinoid processes laterally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What CN deficit is most commonly caused by pituitary adenoma?

A

CN II. Pituitary adenomas are the most common cause of optic chiasm compression. Less commonly, CN III, CN IV, and CN VI deficits can cause ocular motility Sx.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What hormones are secreted by lobes of the pituitary?

A

Anterior: prolactin (PL), GH, ACTH, TSH, LH, FSH
Intermediate: melanocyte-stimulating hormone (MSH)
Posterior: ADH, oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the histopathologic description of the cells of nonfunctional tumors?

A

Histopathologically, the cells of nonfunctional tumors are chromophobic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What hormones are secreted by basophilic cells? Acidophilic cells?

A

Basophilic: ACTH, TSH, LH, FSH
Acidophilic: GH, PL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common functional pituitary tumor? 2nd most common?
3rd most common?

A

Prolactinoma (30%) > GH (25%) > ACTH (∼15%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which pituitary tumors are more common in males and the elderly? Which are more common in females?

A

Males and the elderly: nonfunctioning or GH

Females: PL and ACTH secreting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which are the more common pituitary tumors: micro- or macroadenomas?

A

Macroadenomas (≥1 cm) are the more common pituitary tumors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which are the most common pituitary tumors in females?

A

Microadenomas (<1 cm) are the most common pituitary tumors in females, particularly those that are PL secreting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the most common cause of pituitary dysfunction in adults? Children?

A

Adults: pituitary adenoma
Children: craniopharyngioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What histologic features are prominent in prolactinomas?

A

Calcifications and amyloid deposits are prominent in prolactinomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What immunohistochemical stains are positive in pituitary adenomas?

A

Synaptophysin, chromogranin, and hormone-specific stains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

With what signs/Sx do pts with nonsecretory pituitary tumors present?

A

Bitemporal hemianopsia (optic chiasm compression), HA (↑ ICP), oculomotor deficits: CNs III–IV, VI, V1–V2 (cavernous sinus compression), hydrocephalus (3rd ventricle compression), hyperprolactinemia (disruption of PL suppression from hypothalamus d/t compression of pituitary stalk), or panhypopituitarism (from general glandular disruption).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

With what signs/Sx do pts with secretory pituitary tumors present?

A

Bitemporal hemianopsia (optic chiasm compression), HA (↑ ICP), oculomotor deficits: CNs III–IV, VI, V1–V2 (cavernous sinus compression), hydrocephalus (3rd ventricle compression), hyperprolactinemia (disruption of PL suppression from hypothalamus d/t compression of pituitary stalk), or panhypopituitarism (from general glandular disruption).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

With what signs/Sx do pts with secretory pituitary tumors present?

A
PL secreting (50%): galactorrhea, amenorrhea, infertility, and vaginal dryness for women, loss of libido, erectile dysfunction and infertility for men
GH secreting (25%): acromegaly
ACTH secreting (20%): Cushing Dz
TSH secreting (≤1%): hyperthyroid Sx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the DDx of a pt with a pituitary mass?

A

Pituitary tumor, craniopharyngioma, meningioma, glioma, suprasellar germ cell, mets, and benign lesions (cyst, aneurysm, empty sella syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the workup of a pt with a pituitary tumor?

A

Pituitary tumor workup: H&P (physical: CNs, visual field, endocrinopathy), labs, including hormone levels, thin-slice MRI through the base of skull, and tissue Dx (transsphenoidal resection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What lab findings are suggestive of a prolactinoma?

A

Normal prolactin is ∼2–25. If >100–200, prolactinoma is suspected, particularly in the setting of a pituitary mass.

26
Q

What are other causes of elevated PL?

A

Pregnancy, lactation, polycystic ovary syndrome, hypothyroidism (thyroidreleasing hormone from hypothalamus stimulates PL secretion), seizures, and cirrhosis

27
Q

What lab findings are suggestive of a GH adenoma?

A

GH >10 (not suppressed by glucose) and elevated IGF-1 are findings that suggest GH adenoma.

28
Q

What lab abnormalities are noted in Cushing Dz?

A

High cortisol not suppressed by low-dose dexamethasone and normal or ↑ ACTH

29
Q

What is Cushing syndrome?

A

Cushing syndrome is elevated cortisol d/t a variety of causes (e.g., adrenal production, exogenous use). Pts have low ACTH, unlike in Cushing Dz.

30
Q

What primary malignancies most commonly metastasize to the pituitary?

A

Breast and lung cancer. Usually in the setting of diffuse metastatic Dz with >4 other sites.

31
Q

What are the Tx paradigms of choice for the management of pituitary adenomas?

A

Can consider external RT alone for definitive local Tx with either stereotactic radiosurgery or FSR.

  1. Observation if small, nonsecreting microadenomas or prolactinomas
  2. Medical management with bromocriptine or cabergoline for a microadenoma prolactinoma not causing local Sx. However, 30% cannot tolerate bromocriptine d/t nausea, HA, and fatigue.
  3. Surgical resection if hypersecreting or symptomatic (d/t mass effect for nonsecreting tumors) → observation or postop RT if fail to suppress biochemically.
32
Q

How long does it take for normalization of the PL level to occur after initiating Tx?

A

Normalization of the PL level takes 1–2 mos following the initiation of pharmacologic suppression as compared to 2–5 yrs after radiotherapy.

33
Q

What pharmacologic agents are used for GH-secreting pituitary adenomas?

A

Somatostatin, octreotide, and pegvisomant (GH receptor antagonist)

34
Q

What pharmacologic agents are used for ACTH-secreting pituitary adenomas?

A

Ketoconazole (best), cyproheptadine (inhibits ACTH secretion), mitotane (↓ cortisol synthesis), RU-486 (blocks glucocorticoid receptor), and metyrapone

35
Q

What is the hormone normalization rate after Sg for a hyperfunctioning pituitary tumor?

A

Hormone levels normalize in 80%–90% of those with microadenoma and ∼65% of those with macroadenoma.

36
Q

What types of surgical resection are used for pituitary tumors, and what are the indications?

A

Transsphenoidal microsurgery: for microadenomas, decompression, debulking of large tumors, reducing hyperfunctioning tumors
Frontal craniotomy: for large tumors with invasion into cavernous sinus, frontal/temporal lobes

37
Q

What are the LC rates after transsphenoidal resection? Are they better for macroadenomas or microadenomas?

A

95%. LC rates are better for microadenomas after surgical resection

38
Q

What are some poor prognostic factors after transsphenoidal resection of prolactinoma?

A

Size >2 cm, high preop PL level, ↑ age, and longer duration of amenorrhea

39
Q

What are some poor prognostic factors after surgical resection of GH secreting tumors?

A

High preop GH and somatomedin-C levels, tumors >1 cm, and extrasellar extension

40
Q

Which pituitary tumors have a high recurrence rate after resection?

A

TSH-secreting tumors (risk factors: Hx of thyroid ablation, Hashimoto thyroiditis, prior RT/Sg)

41
Q

What are the indications for radiotherapy in the Tx of pituitary tumors?

A

Pituitary tumor indications for radiotherapy:
1. Medically inoperable or otherwise not felt to be good surgical candidate d/t
proximity to vessels or cavernous sinus.
2. Persistence of hormone defect after Sg
3. Macroadenoma with STR or decompression
4. Recurrent tumor after Sg

42
Q

What are the long-term control rates for hormone-secreting tumors after RT?

A

Best outcomes with RT for GH-secreting tumors (80%) > ACTH (50%–80%) > PL (30%–40%)

43
Q

What should be done with medical/pharmacologic Tx before initiating RT for pituitary adenomas?

A

Medical Tx needs to be D/C b/c of lower RT sensitivity with concurrent medical Tx. (Landolt AM et al., J Clin Endocrinol Metab 2000)

44
Q

What is the typical LC rate with RT for pituitary tumors?

A

The LC after RT is >90% for most pituitary tumors. (Loeffler JS et al., J Clin Endocrinol Metab 2011)

45
Q

What are the typical RT volumes and doses used for pituitary tumors?

A

With IMRT or proton beam therapy: Treat operative bed + gross Dz + 0.3–0.5 cm PTV; 45–50.4 Gy in 1.8 Gy/fx if postop with no gross Dz, 54 Gy for gross Dz.

46
Q

What evidence supports at least 45 Gy as the min effective RT dose for pituitary tumor control?

A

Older Florida data (McCollough WM et al., IJROBP 1991): 10-yr LC was 95%.

47
Q

What are the indications for and the benefits of SRS in the Tx of pituitary adenomas?

A

SRS is used for microadenomas and yields better control of hormone secretion (same LC as fractionated and is more convenient).

48
Q

What are the typical SRS doses used for functional vs. nonfunctional tumors?

A

Functional SRS dose: ∼20 Gy

Nonfunctional SRS dose: ∼14–18 Gy

49
Q

What are the differences b/t LINAC-based and GK-based SRS for pituitary tumors?

A

With GK, there is less homogeneous dose to the tumor, more precise setup, and slightly less normal tissue treated (similar outcomes/conformality can be achieved with LINAC-based SRS, however).

50
Q

When is FSR preferred instead of SRS for pituitary adenomas?

A

FSR is preferred when the pituitary lesion is >3 cm and/or the lesion is <3 mm from the chiasm.

51
Q

What RT doses are used with fractionated EBRT?

A

45–50 Gy (nonfunctioning), 50–54 Gy (functioning).

52
Q

What form of RT can be used to reduce dose to normal tissues with fractionated EBRT?

A

Proton therapy. The Loma Linda experience showed it to be effective. (Ronson BB et al., IJROBP 2006) However, long-term results needed to determine clinical results from normal tissue sparing.

53
Q

What is the most common toxicity of pituitary irradiation?

A

Hypopituitarism. Risk is ∼20% at 10 yrs post Tx (Brada et al., Clin Endocrinol 2002) with FSR or SRS. (Sheehan et al., J Neurosurg 2013)

54
Q

What is the RT TD 5/5 TD threshold for developing hypopituitarism?

A

The TD 5/5 is 40–45 Gy. GH levels ↓ 1st, then LH/FSH → TSH/ACTH.

55
Q

What are the main benefits of using SRS for pituitary adenomas?

A

Benefits of SRS include ↓ neurocognitive sequelae and possible preservation of normal pituitary function by reducing the dose to the hypothalamus (↑ risk of damage to the optic nerve/chiasm).

56
Q

What is the best way to assess the response to RT in GH-secreting tumors?

A

The response to RT can be assessed by monitoring IGF-1 levels.

57
Q

What hormone is the 1st to respond/decrease after RT?

A

GH is the 1st hormone to respond/decrease after RT.

58
Q

What is the operative mortality/complication rate after Sg?

A

Mortality: 1%–2%

Complication rate: 15%–20%

59
Q

What are the most common surgical complications after resection of pituitary tumors?

A

DI (6%) → hyponatremia and CSF leak

60
Q

Which pituitary pts/tumor types are prone to increased rates of 2nd malignancies after Tx with RT?

A

Men with GH-secreting pituitary adenomas tend to have increased rates of 2nd malignancies after RT. (Norberg L et al., Clin Endocrinol 2007)